Mo1093 ALPN-101, A FIRST-IN-CLASS DUAL ICOS/CD28 ANTAGONIST, DEMONSTRATES EFFICACY IN PATIENT-DERIVED PBMC IN VITRO AND IN AN IN VIVO T CELL TRANSFER MODEL OF CHRONIC INFLAMMATORY BOWEL DISEASE (IBD)

Saved in:
Bibliographic Details
Published inGastroenterology (New York, N.Y. 1943) Vol. 158; no. 6; p. S-786
Main Authors Dillon, Stacey R., Evans, Lawrence S., Bort, Susan, Mudri, Sherri, Lewis, Katherine, Rixon, Mark, Bhandari, Janhavi, Peng, Stanford, Swiderek, Kristine M.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.05.2020
Online AccessGet full text

Cover

More Information
ISSN:0016-5085
1528-0012
DOI:10.1016/S0016-5085(20)32636-6